Moreover, years later, Naarman-de Vries IS et al. found that the 9q21.32 deletion produces a reduction in hnRNP K-targeted gene expression, such as CDKN1A and CEBPA, which is related to AML del(9q) pathogenesis. This evidence concerns the gene HNRNPK and acute myeloid leukemia.